← Back to All Filings

Cognizant Officer Files Form 144 for Routine Share Sale Under Rule 10b5-1

Low SignificanceSeptember 14, 2026 at 5:14:52 PM EDT

Subscribe to track CTSH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

šŸ“‹ Form 144 Notice of Proposed Sale: COGNIZANT TECHNOLOGY SOLUTIONS CORP ($CTSH) • Insider: ALINA KERDMAN (Officer) • Shares Proposed to Sell: 134 Common shares • Aggregate Market Value: ~$8,040.00 • Approx. Sale Date: 09/14/2026 • Trading Plan: Adopted under Rule 10b5-1 on 08/19/2025 • Significance: Low

Comprehensive Analysis

Executive Summary

On September 14, 2026, Alina Kerdman, an Officer at Cognizant Technology Solutions Corp ($CTSH), filed Form 144 proposing the sale of 134 common shares with an estimated aggregate market value of $8,040.00 through Morgan Stanley Smith Barney LLC.

Transaction & Plan Details

  • Proposed Sale: 134 shares (approximate market price of ~$60.00 per share).
  • Acquisition Origin: Acquired via Restricted Stock Unit (RSU) vesting on June 15, 2026.
  • Pre-set Trading Plan: The transaction is scheduled in accordance with a Rule 10b5-1 trading plan adopted on August 19, 2025.
  • Past 3 Months Activity: The filer previously completed three 10b5-1 sales: 133 shares on June 15, 2026 ($6,876.10), 137 shares on July 1, 2026 ($5,455.34), and 144 shares on August 31, 2026 ($9,120.96).

Market & Trading Impact

  • Significance: Low. The volume and dollar value are minimal relative to Cognizant's market capitalization and 450.44M outstanding shares. The planned disposition represents standard, scheduled equity monetization and does not indicate a shift in fundamental sentiment.
Topics:#Cognizant#CTSH#Form144#InsiderTrading#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.